Rafferty Asset Management
CRMD icon

Rafferty Asset Management’s CorMedix CRMD Stock Holding History

Rafferty Asset Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$131K Buy
16,705
+2,930
+21% +$23.1K ﹤0.01% 1124
2026
Q1 		$93.5K Sell
13,775
-3,989
-22% -$29.5K ﹤0.01% 1049
2025
Q4 		$207K Buy
17,764
+2,777
+19% +$30.7K ﹤0.01% 1099
2025
Q3 		$174K Buy
+14,987
New +$181K ﹤0.01% 1081
2025
Q1 		– Sell
-14,857
Closed -$120K – 1086
2024
Q4 		$120K Buy
+14,857
New +$148K ﹤0.01% 1121

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Rafferty Asset Management's CRMD Position: Q2 2026 in Review

Rafferty Asset Management increased its CorMedix (CRMD) stake by 21% in Q2 2026, buying an estimated $23.1K and bringing the position to 16,705 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #1124.

Rafferty Asset Management first reported a position in CRMD in Q4 2024 and has held it in 5 quarters since. The position peaked at $207K in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Rafferty Asset Management held 16,705 shares of CorMedix worth $131K as of Q2 2026.
  • Rafferty Asset Management bought 2,930 CorMedix shares in Q2 2026, an estimated $23.1K.
  • CorMedix made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #1124 holding.
  • Rafferty Asset Management first reported a position in CorMedix in Q4 2024 and has held it in 5 quarters since.
  • Rafferty Asset Management's CorMedix position peaked at $207K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.